Identification of Sp1 and GC-boxes as transcriptional regulators of mouse Dag1 gene promoter

American Journal of Physiology - Cell Physiology

Volumn 297, Issue 5, 2009, Pages

  Rettino, Alessandro ^a   Rafanelli, Francesca ^a   Genovese, Giannicola ^a   Goracci, Martina ^a   Cifarelli, Rosa Anna ^c   Cittadini, Achille ^a,b   Sgambato, Alessandro ^a,b  

^a CATHOLIC UNIVERSITY   (Italy)

^b REFERRAL CANCER CENTER OF BASILICATA   (Italy)

^c MADONNA DELLE GRAZIE HOSPITAL   (Italy)

Author keywords

Dystroglycan; Epigenetic modification; Gene expression; Muscle differentiation; Promoter

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DYSTROGLYCAN; HISTONE DEACETYLASE INHIBITOR; RNA; TATA BINDING PROTEIN; TRANSCRIPTION FACTOR SP1; TRICHOSTATIN A;

ARTICLE; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; DAG1 GENE; DNA FLANKING REGION; DNA METHYLATION; DOWN REGULATION; E BOX ELEMENT; GC RICH SEQUENCE; GENE; GENE REGULATORY NETWORK; GENETIC TRANSFECTION; MOUSE; MUSCLE CELL; MYOBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN METHYLATION; TRANSCRIPTION REGULATION;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; DIACYLGLYCEROL KINASE; DNA METHYLATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; IMMUNOPRECIPITATION; MICE; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC;

EID: 70449657564     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00189.2009     Document Type: Article

References (50)

1. Adams M, Dwyer T, Dowler L, White R, Froehner S. Mouse 1- and 2-syntrophin gene structure, chromosome localization, and homology with a discs large domain. J Biol Chem 270: 25859-25865, 1995.
2. Barresi R, Campbell K. Dystroglycan: from biosynthesis to pathogenesis of human disease. J Cell Sci 119: 199-207, 2006. (Pubitemid 43210689)
3. Bessereau JL, Mendelzon D, LePoupon C, Fiszman M, Changeux J, Piette J. Muscle-specific expression of the acetylcholine receptor alphasubunit gene requires both positive and negative interactions between myogenic factors, Sp1 and GBF factors. EMBO J 12: 443-449, 1993. (Pubitemid 23073690)
4. Bhavsar P, Dellow K, Yacoub M, Brand N, Barton P. Identification of cis-acting DNA elements required for expression of the human cardiac troponin I gene promoter. J Mol Cell Cardiol 32: 95-108, 2000. (Pubitemid 30064308)
5. Biesiada E, Hamamori Y, Kedes L, Sartorelli V. Myogenic basic helix-loop-helix proteins and Sp1 interact as components of a multiprotein transcriptional complex required for activity of the human cardiac alpha-actin promoter. Mol Cell Biol 19: 2577-2584, 1999. (Pubitemid 29144501)
6. Black A, Black J, Azizkhan-Clifford J. Sp1 and krüppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 188: 143-160, 2001. (Pubitemid 32622905)
7. Blake M, Jambou R, Swick A, Kahn J, Azizkhan J. Transcriptional initiation is controlled by upstream GC-box interactions in a TATAA-less promoter. Mol Cell Biol 10: 6632-6641, 1990. (Pubitemid 120004608)
8. Bouwman P, Philipsen S. Regulation of the activity of Sp1-related transcription factors. Mol Cell Endocrinol 195: 27-38, 2002.
9. Brunk B, Goldhamer D, Emerson C Jr. Regulated demethylation of the MyoD distal enhancer during skeletal myogenesis. Dev Biol 177: 490-503, 1996. (Pubitemid 26275900)
10. Cohn RD, Henry MD, Michele DE, Barresi R, Saito F, Moore SA, Flanagan JD, Skwarchuk MW, Robbins ME, Mendell JR, Williamson RA, Campbell KP. Disruption of DAG1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration. Cell 110: 639-648, 2002.
11. Durbeej M, Campbell KP. Biochemical characterization of the epithelial dystroglycan complex. J Biol Chem 274: 26609-26616, 1998.
12. Durbeej M, Henry MD, Ferletta M, Campbell KP, Ekblom P. Distribution of dystroglycan in normal adult mouse tissues. J Histochem Cytochem 46: 449-457, 1998. (Pubitemid 28158464)
13. Durbeej M, Talts JF, Henry MD, Yurchenco PD, Campbell KP, Ekblom P. Dystroglycan binding to laminin a1LG4 module influences epithelial morphogenesis of salivary gland and lung in vitro. Differentiation 69: 121-134, 2001. (Pubitemid 33755061)
14. Figliola R, Busanello A, Vaccarello G, Maione R. Regulation of p57(KIP2) during muscle differentiation: role of Egr1, Sp1 and DNA hypomethylation. J Mol Biol 380: 265-277, 2008.
15. Guo C, Degnin C, Fiddler T, Stauffer D, Thayer M. Regulation of MyoD activity and muscle cell differentiation by MDM2, pRb, and Sp1. J Biol Chem 278: 22615-22622, 2003. (Pubitemid 36830319)
16. Haliloglu G, Topaloglu H. Glycosylation defects in muscular dystrophies. Curr Opin Neurol 17: 521-527, 2004.
17. Hasty P, Bradley A, Morris J, Edmondson D, Venuti J, Olson E, Klein W. Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature 364: 501-506, 1993. (Pubitemid 23273093)
18. Henry MD, Campbell KP. A role for dystroglycan in basement membrane assembly. Cell 95: 859-870, 1998. (Pubitemid 29014465)
19. Henry MD, Cohen MB, Campbell KP. Reduced expression of dystroglycan in breast and prostate cancer. Hum Pathol 32: 791-795, 2001. (Pubitemid 32803978)
20. Jost JP, Jost YC. Transient DNA demethylation in differentiating mouse myoblasts correlates with higher activity of 5-methyldeoxycytidine excision repair. J Biol Chem 269: 10040-10043, 1994.
21. Jost JP, Oakeley E, Zhu B, Benjamin D, Thiri S, Siegman M, Jost YC. Methylcytosine DNA glycosylase participates in the genome wide loss of DNA methylation occurring during mouse myoblast differentiation. Nucleic Acids Res 29: 4452-4461, 2001. (Pubitemid 33064786)
22. Le H, Vaisanen PA, Johnson J, Raney A, McLachlan A. Regulation of transcription from the human muscle phosphofructokinase P2 promoter by the Sp1 transcription factor. DNA Cell Biol 13: 473-485, 1994. (Pubitemid 24291401)
23. Lederfein D, Yaffe D, Nudel U. A housekeeping type promoter, located in the 3′ region of the Duchenne muscular dystrophy gene, controls the expression of Dp71, a major product of the gene. Hum Mol Genet 2: 1883-1888, 1993.
24. Lin H, Yutzey K, Konieczny S. Muscle-specific expression of the troponin I gene requires interactions between helix-loop-helix muscle regulatory factors and ubiquitous transcription factors. Mol Cell Biol 11: 267-280, 1991. (Pubitemid 21895204)
25. Lu J, Lee W, Jiang C, Keller E. Start site selection by Sp1 in the TATA-less human Ha-ras promoter. J Biol Chem 269: 5391-5402, 1994. (Pubitemid 24239538)
26. Moran J, Li Y, Hill A, Mounts W, Miller C. Gene expression changes during mouse skeletal myoblast differentiation revealed by transcriptional profiling. Physiol Genomics 10: 103-111, 2002.
27. Muschler J, Levy D, Boudreau R, Henry M, Campbell K, Bissell MJ. A role for dystroglycan in epithelial polarization: loss of function in breast tumor cells. Cancer Res 62: 7102-7109, 2002. (Pubitemid 35424106)
28. Rudnicki M, Schnegelsbery P, Stead R, Braun T, Arnold H, Jaenisch R. MyoD or Myf5 is required for the formation of skeletal muscle. Cell 75: 1351-1359, 1993. (Pubitemid 24021909)
29. Sartorelli V, Caretti G. Mechanisms underlying the transcriptional regulation of skeletal myogenesis. Curr Opin Genet Dev 15: 528-535, 2005. (Pubitemid 41262409)
30. Sartorelli V, Webster K, Kedes L. Muscle-specific expression of the cardiac alpha-actin gene requires MyoD1, CArG-box binding factor, and Sp1. Genes Dev 4: 1811-1822, 1990.
31. Sato T, Furukawa K. Transcriptional regulation of the human beta-1,4- galactosyltransferase V gene in cancer cells: essential role of transcription factor Sp1. J Biol Chem 279: 39574-39583, 2004. (Pubitemid 39258224)
32. Sgambato A, Brancaccio A. The dystroglycan complex: from biology to cancer. J Cell Physiol 205: 163-169, 2005.
33. Sgambato A, Camerini A, Montanari M, Camerini A, Brancaccio A, Spada D, Cangiano R, Losasso C, Capelli G, Trentini G, Cittadini A. Increased expression of dystroglycan inhibits the growth and tumorigenicity of human mammary epithelial cells. Cancer Biol Ther 3: 849-860, 2004.
34. Sgambato A, De Paola B, Migaldi M, Di Salvatore M, Rettino A, Rossi G, Faraglia B, Boninsegna A, Maiorana A, Cittadini A. Dystroglycan expression is reduced during prostate tumorigenesis and is regulated by androgens in prostate cancer cells. J Cell Physiol 213: 528-539, 2007. (Pubitemid 47509736)
35. Sgambato A, Di Salvatore M, De Paola B, Rettino A, Faraglia B, Boninsegna A, Graziani C, Camerini A, Proietti G, Cittadini A. Analysis of dystroglycan regulation and functions in mouse mammary epithelial cells and implications for mammary tumorigenesis. J Cell Physiol 207: 520-529, 2006.
36. Sgambato A, Migaldi M, Montanari M, Camerini A, Brancaccio A, Rossi G, Cangiano R, Losasso C, Capelli G, Trentini GP, Cittadini A. Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression. Am J Pathol 162: 849-860, 2003. (Pubitemid 36237493)
37. Singh J, Itahana Y, Knight-Krajewski S, Kanagawa M, Campbell KP, Bissell MJ, Muschler J. Proteolytic enzymes and altered glycosylation modulate dystroglycan function in carcinoma cells. Cancer Res 64: 6152-6159, 2004. (Pubitemid 39129416)
38. Smale S. Transcription initiation from TATA-less promoters within eukaryotic protein-coding genes. Biochim Biophys Acta 1351: 73-88, 1997.
39. Struhl K. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev 12: 599-606, 1998. (Pubitemid 28134293)
40. Suske G. The Sp-family of transcription factors. Gene 238: 291-300, 1999.
41. Suske G, Bruford E, Philipsen S. Mammalian SP/KLF transcription factors: bring in the family. Genomics 85: 551-556, 2005. (Pubitemid 40463690)
42. Takai D, Jones P. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci USA 99: 3740-3745, 2002. (Pubitemid 34252176)
43. Tang H, Veldman M, Goldman D. Characterization of a muscle-specific enhancer in human MuSK promoter reveals the essential role of myogenin in controlling activity-dependent gene regulation. J Biol Chem 281: 3943-3953, 2006.
44. Tapscott S. The circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription. Development 132: 2685-2695, 2005.
45. Viñals F, Fandos C, Santalucia T, Ferré J, Testar X, Palacín M, Zorzano A. Myogenesis and MyoD down-regulate Sp1. A mechanism for the repression of GLUT1 during muscle cell differentiation. J Biol Chem 272: 12913-12921, 1997. (Pubitemid 27216706)
46. Walke W, Xiao G, Goldman D. Identification and characterization of a 47 base pair activity-dependent enhancer of the rat nicotinic acetylcholine receptor delta-subunit promoter. J Neurosci 16: 3641-3651, 1996. (Pubitemid 26149501)
47. Wheeler M, Snyder E, Patterson M, Swoap S. An E-box within the MHC IIB gene is bound by MyoD and is required for gene expression in fast muscle. Am J Physiol Cell Physiol 276: C222-C223, 1999.
48. Williamson RA, Henry MD, Daniels KJ, Hrstka RF, Lee JC, Sunada Y, Ibraghimov-Beskrovnaya O, Campbell KP. Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice. Hum Mol Genet 6: 831-841, 1997. (Pubitemid 27239066)
49. Winder SJ. The complexities of dystroglycan. Trends Biochem Sci 26: 118-124, 2001.
50. Zhao P, Seo J, Wang Z, Wang Y, Shneiderman B, Hoffman E. In vivo filtering of in vitro MyoD target data: an approach for identification of biologically relevant novel downstream targets of transcription factors. CR Biol 326: 1049-1065, 2003.